Concepedia

Jianjun Xu

JX

25

Publications

838

Citations

16

H-Index

2000

Active since

Affiliations

Kagoshima University(Current)

China Medical University

Gilead Sciences (United States)

Shenyang Pharmaceutical University

Northeastern University

Jianjun Xu is an author at Kagoshima University specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2000–2024

25

Publications

25

Discovery of GS-9973, a Selective and Orally Efficacious Inhibitor of Spleen Tyrosine Kinase

Kevin Currie, Jeffrey E. Kropf, Tony Lee et al. · Journal of Medicinal Chemistry · 2014 · 167 citations · Full text

, , +18

Opposite Functions of Histamine H<sub>1</sub> and H<sub>2</sub> Receptors and H<sub>3</sub> Receptor in Substantia Nigra Pars Reticulata

Fu‐Wen Zhou, Jianjun Xu, Yu Zhao et al. · Journal of Neurophysiology · 2006 · 71 citations

A chemical chaperone improves muscle function in mice with a RyR1 mutation

Chang Seok Lee, Amy D. Hanna, Hui Wang et al. · Nature Communications · 2017 · 67 citations · Full text

Potent and selective Bruton’s tyrosine kinase inhibitors: Discovery of GDC-0834

Wendy B. Young, J A Barbosa, Peter Blomgren et al. · Bioorganic & Medicinal Chemistry Letters · 2015 · 64 citations · Full text

, , +11

Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases

Peter Blomgren, Jayaraman Chandrasekhar, Julie A. Di Paolo et al. · ACS Medicinal Chemistry Letters · 2020 · 49 citations · Full text

, , +15

Rows per page

1–5 of 25